Cargando…

Clinical analysis of EV‐Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy

BACKGROUND: There is an unmet clinical need for minimally invasive diagnostic tests to improve the detection of grade group (GG) ≥3 prostate cancer relative to prostate antigen‐specific risk calculators. We determined the accuracy of the blood‐based extracellular vesicle (EV) biomarker assay (EV Fin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fairey, Adrian, Paproski, Robert J., Pink, Desmond, Sosnowski, Deborah L., Vasquez, Catalina, Donnelly, Bryan, Hyndman, Eric, Aprikian, Armen, Kinnaird, Adam, Beatty, Perrin H., Lewis, John D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469644/ https://www.ncbi.nlm.nih.gov/pubmed/37329212 http://dx.doi.org/10.1002/cam4.6216

Ejemplares similares

Cover Image
por: Fairey, Adrian, et al.
Publicado: (2023)

Building predictive disease models using extracellular vesicle microscale flow cytometry and machine learning
por: Paproski, Robert J., et al.
Publicado: (2022)

Cohort profile: the Alberta Prostate Cancer Research Initiative (APCaRI) Registry and Biorepository facilitates technology translation to the clinic through the use of linked, longitudinal clinical and patient-reported data and biospecimens from men in Alberta, Canada
por: Vasquez, Catalina, et al.
Publicado: (2020)

Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening
por: Zakaria, Ahmed S., et al.
Publicado: (2018)

Improving ultrasound-based prostate volume estimation
por: Aprikian, Saro, et al.
Publicado: (2019)

The mass of cosmic rays above $10^{17}$eV
por: Dova, M T
Publicado: (2005)

Clinical Management and Burden of Prostate Cancer: A Markov Monte Carlo Model
por: Sanyal, Chiranjeev, et al.
Publicado: (2014)

Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec
por: Hu, Jason, et al.
Publicado: (2022)

Clusters of Cosmic Rays above $4.10^{19}$ eV
por: Mikhailov, A A
Publicado: (2005)

Drug costs in the management of metastatic castration-resistant prostate cancer in Canada
por: Dragomir, Alice, et al.
Publicado: (2014)

Studies of Air Showers above $10^{18}$eV with the CHICOS Array
por: Lynn, T W
Publicado: (2005)

EAS Core Structure above 10<sup>16</sup>eV
por: Kuramochi, H
Publicado: (2005)

The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases
por: Chevalier, Simone, et al.
Publicado: (2015)

PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity
por: Choucair, Khalil, et al.
Publicado: (2012)

Active surveillance for low-risk prostate cancer: well established, yet avoided?
por: Sosnowski, Roman, et al.
Publicado: (2022)

The cosmic ray energy spectrum above 10$^{19}$ eV determined by AGASA
por: Doi, T, et al.
Publicado: (1997)

Cosmic ray spectrum above $10^{15}$eV: a new approach
por: Petrukhin, A A
Publicado: (2005)

Liquid biopsy‐based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer
por: Derderian, Seta, et al.
Publicado: (2022)

Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies
por: Steuber, Thomas, et al.
Publicado: (2018)

Metabolic syndrome and prostate cancer risk in a population-based case–control study in Montreal, Canada
por: Blanc-Lapierre, Audrey, et al.
Publicado: (2015)

An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies
por: Jager, Auke, et al.
Publicado: (2022)

The Health Economics of Metastatic Hormone-Sensitive and Non-Metastatic Castration-Resistant Prostate Cancer—A Systematic Literature Review with Application to the Canadian Context
por: Yanev, Ivan, et al.
Publicado: (2022)

Adherence to oral hormonal therapy in advanced prostate cancer: a scoping review
por: Fleshner, Neil E., et al.
Publicado: (2023)

Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis
por: Mahmud, S, et al.
Publicado: (2004)

Point source search for cosmic rays above 3 x 10$^{17}$ eV by AGASA
por: Doi, T, et al.
Publicado: (1996)

Inclined giant air showers with energies above 10$^{19.5}$ eV observed by AGASA
por: Doi, T, et al.
Publicado: (1996)

Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
por: Schoots, Ivo G., et al.
Publicado: (2020)

Multicenter Repeatability and Reproducibility of MR Fingerprinting in Phantoms and in Prostatic Tissue
por: Lo, Wei‐Ching, et al.
Publicado: (2022)

Ciprofloxacin Alone vs. Ciprofloxacin plus an Aminoglycoside for the Prevention of Infectious Complications following a Transrectal Ultrasound-Guided Prostate Biopsy: A Retrospective Cohort Study
por: Thirion, Daniel J. G., et al.
Publicado: (2022)

Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer
por: Rouleau, Michèle, et al.
Publicado: (2022)

Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance
por: Kotb, A F, et al.
Publicado: (2011)

How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density
por: Kim, Jae Yeon, et al.
Publicado: (2023)

Asporin is a stromally expressed marker associated with prostate cancer progression
por: Rochette, Annie, et al.
Publicado: (2017)

Differences in prostate cancer detection between Canadian and Saudi populations
por: Al-Abdin, O.Z., et al.
Publicado: (2013)

Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml
por: Koo, Jin Mo, et al.
Publicado: (2010)

Characteristics of muonic and electromagnetic components far from the core of giant air showers above $10^{18}eV$
por: Honda, K, et al.
Publicado: (1997)

Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression
por: Derderian, Seta, et al.
Publicado: (2023)

Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer
por: Oeyen, Steffi, et al.
Publicado: (2020)

Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies
por: Bertok, Tomas, et al.
Publicado: (2020)

Early detection of clinically significant prostate cancer at diagnosis: a prospective study using a novel panel of TMPRSS2:ETS fusion gene markers
por: Chan, Sam W., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_heh6p10kvpvacaq5fp2qrcclin